Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection. - Wikidata - wikimedia - TriplyDB

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

http://www.wikidata.org/entity/Q40410213

about

Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin.Microvascular injury after lung transplantation The role of hyaluronan in the pathobiology and treatment of respiratory disease.Vitamin D inhibits lymphangiogenesis through VDR-dependent mechanisms.Danger signals in regulating the immune response to solid organ transplantation.Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses.Airway remodelling in the transplanted lung.Mechanisms of graft rejection after lung transplantation.Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?HA-ving lymphatics improves lung transplantation.The Lymphatic System: Integral Roles in Immunity.Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction A Critical Role for Airway Microvessels in Lung Transplantation.Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.Lymphatic Vessels: The Next Frontier in Lung Transplant.Hyaluronan interactions with innate immunity in lung biology.Lymphangiogenesis in rat asthma model.Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis

P2860

Q30352802-D400836E-298C-48F2-A42F-A24FE8AF7250 Q33860126-0D803CF5-47C6-4FAE-A9C4-E1E1441B87CE Q36893931-8AE18CDD-8B64-4AB5-BD05-48E9DF8CAA49 Q36902371-D8F15180-3B6A-43B1-B710-C173BC1707C4 Q37707913-695A8A5F-6E1D-428A-8F7D-BD17A2610CEC Q38771577-53339F59-1B1C-4345-B77B-1A9D7A7125F8 Q38845953-74115839-F7FA-4235-A22C-1282D3863CB2 Q39006011-AA541D23-CEBE-43CD-B2E6-1D60A2BDAD88 Q39012703-B762973C-B6CD-444B-B81A-2C4AC1CB97EF Q39263241-4AB3005F-235A-4A2D-B157-80F0C8A95540 Q40366865-368F0C64-B7C1-4753-8747-4CDB472A411B Q41340368-9CD80AFC-F27C-4396-9F2D-B902E09D318D Q42126369-D7A53C40-CC41-48E3-9B65-A51402DAF9FA Q42911358-03186154-EDB9-466C-AACE-F65BCCF6AB5B Q47940254-E12EC10B-1C04-4AB5-8BDA-73CDC3EE6F1F Q49847182-6152CE44-269E-471B-AA11-58F0639D4934 Q50150200-E0F51711-7332-44FD-B066-F7A5E4F4AD22 Q50273163-F15D124F-70E9-4930-871F-42BE4302BAB6 Q50419857-59A4CFAE-7305-413E-8D14-3CDB94774296 Q58710420-1D789484-62C2-4467-B7B5-4EB7CDE83C46

P2860

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

http://www.wikidata.org/entity/Q40410213

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

@en

type

label

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

@en

prefLabel

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

@en

P1433

Q40410213-E64E16A5-5989-4DBC-9298-166DA394FE8A

P1476

Q40410213-8B6263D3-ECAA-4E5D-9B8A-4899975D1FE4

P2093

Q40410213-1C870801-845C-43CA-ABCA-A413D7B76E67

Q40410213-49EBA2EE-8163-4E54-B105-82B69415E205

Q40410213-4E542000-939F-4AA7-8649-91C34A0544DE

Q40410213-56878841-83D6-4328-A77C-75CBBCBD4079

Q40410213-62D5567E-83C1-4A5E-B078-25A7736F5AC1

Q40410213-700EA20E-8DA4-4CE3-A8D5-3861C503E255

Q40410213-904C96FC-8E17-4433-BEF0-24CBD6B3E266

Q40410213-9071A7AE-4172-4969-A3C1-8F80BA43AB9E

Q40410213-A556E4A1-691F-4B43-9032-E7051E7DCBE7

Q40410213-ACF6ED4B-3021-40A6-B7E6-6F70C4403A99

P2860

Q40410213-09DC4A99-9FD4-4554-B0E4-41672D429AA6

Q40410213-0CD7D552-5409-4CB3-8B61-378BADD009B6

Q40410213-141067F2-30FF-4A10-A86E-0C111A11DC88

Q40410213-225E84ED-BCF6-40E5-8887-018BC2F3A2D1

Q40410213-23047D57-6716-4F94-82C2-AE32AF99EA16

Q40410213-2746AE7D-CC04-492F-8249-A05F74C4B3FE

Q40410213-27AF92BD-BD73-4C9B-B433-4FAF6498786F

Q40410213-2BE17F0C-2E54-4160-95B1-36305230596A

Q40410213-2CD765D4-2364-4DFF-B91D-AFB740F36417

Q40410213-2E1D6ED5-CB0F-4A2A-A3C7-FD807EB28895

P304

Q40410213-3A41F224-23B6-4442-AEF0-43C34DF1E922

P31

Q40410213-EDA1613F-B071-48C6-AC7B-2B94BA465921

P356

Q40410213-2EDFD598-0A6D-4F28-B27D-37DF1B089816

P407

Q40410213-AC5F6FAB-3EB1-4BEE-8A40-B876DA105853

P433

Q40410213-9766E6B8-509E-4903-AFF3-F11D72344B6A

P478

Q40410213-0D1E92C0-97D9-4F01-AF5F-6FB301AA450D

P577

Q40410213-1BD9A8B2-ACCF-4435-852D-E7ED0D6C28E1

P698

Q40410213-903B65C4-29FD-4357-9889-DAEAB6EE5F34

P921

Q40410213-F09C687C-64CD-483F-9040-56A03ECE772F

P932

Q40410213-55DB6DC6-7800-4759-8732-3F1EC0AEC895

P356

P1433

Journal of Clinical Investigation

P1476

Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

@en

P2093

Demet Toprak

http://www.w3.org/2001/XMLSchema#string

Elie Abdelnour

http://www.w3.org/2001/XMLSchema#string

Emmanuel D'Agostino

http://www.w3.org/2001/XMLSchema#string

Gary Visner

http://www.w3.org/2001/XMLSchema#string

Gautam George

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Hilary J Goldberg

http://www.w3.org/2001/XMLSchema#string

Ivan O Rosas

http://www.w3.org/2001/XMLSchema#string

Kaifeng Liu

http://www.w3.org/2001/XMLSchema#string

Maria E Monzon-Medina

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Visualization of intrapulmonary lymph vessels in healthy and inflamed murine lung using CD90/Thy-1 as a marker

Emerging roles of lymphatic endothelium in regulating adaptive immunity.

LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis

Resolution of lung inflammation by CD44

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway

Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Central memory CD8+ T lymphocytes mediate lung allograft acceptance.

Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.

P304

4255-4268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI79693

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26485284

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

4639995

http://www.w3.org/2001/XMLSchema#string